I1DX34:BVMF
Idexx Laboratories
R$ 516,36
0,00%
(0,00) 1D
9 de out., 16:56:00 GMT-3 · BRL
search
Todos os ativos
| Códigos | Preço | Variação | % de variação |
|---|
insights_autoGerando os principais insights para I1DX34…
Abrir
R$ 516,36
Alta
R$ 516,36
Baixa
R$ 516,36
Valor de mercado
41,28 bi
Volume médio
6,00
Volume
5,00
Alto — 52 sem
R$ 813,60
Baixo — 52 sem
R$ 509,99
Ações em circulação
78,78 mi
Nº de funcionários
11 mil
Abrir
R$ 516,36
Alta
R$ 516,36
Baixa
R$ 516,36
Valor de mercado
41,28 bi
Volume médio
6,00
Volume
5,00
Alto — 52 sem
R$ 813,60
Baixo — 52 sem
R$ 509,99
Ações em circulação
78,78 mi
Nº de funcionários
11 mil
Notícias
De fontes da web e parceiros de notícias
Investing.com
·
há 16 horas
KeyBanc initiates Idexx Laboratories stock rating at Sector Weight
Perfil
IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs about 11,000 people in full-and part-time positions.
In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.
In 2025, IDEXX estimated annual sales between $4.21 billion and $4.28 billion, with total quarterly revenue exceeding $1 billion. Wikipedia
Sobre Idexx Laboratories
CEOJay Mazelsky
Funcionários11 mil
Data de fundação19 de dez. de 1983
SedeWestbrook, Maine, Estados Unidos
Setor-
Siteidexx.com